Bioresorbable stent implantation to treat coronary artery disease
KEYWORDS: coronary, artery, coronary artery, bioresorbable, procedure, stent, evidence, risk, disease, bioresorbable stent, usually, artery disease, passed, balloon, stents

after the procedure. 3 Committee considerations The evidence 3.1 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 13 sources, which was discussed by the committee. The evidence included 1 health technology assessment, 2 randomised controlled trials, 3 systematic reviews with meta-analysis, 5 case series and 2 case reports. It is presented in the summary of key evidence section in the interventional procedures overview. Other relevant literature is in the appendix of the overview. 3.2 The professional experts and the committee considered the key efficacy outcomes to be: reduced coronary insufficiency symptoms, maintenance of coronary patency, a reduced myocardial infarction rate and reduced mortality. 3.3 The professional experts and the committee considered the key safety outcomes to be: death, myocardial infarction, in-stent thrombosis and need for further intervention. 3.4 Patient commentary was sought but none was received.
